VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 183 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $614,000 | +41.8% | 28,500 | -0.9% | 0.01% | +40.0% |
| Q1 2021 | $433,000 | +12.2% | 28,769 | -2.0% | 0.01% | 0.0% |
| Q4 2020 | $386,000 | +38.8% | 29,369 | +2.1% | 0.01% | +25.0% |
| Q3 2020 | $278,000 | -83.7% | 28,769 | -80.6% | 0.00% | -83.3% |
| Q2 2020 | $1,701,000 | +10.2% | 148,669 | -0.2% | 0.02% | -4.0% |
| Q1 2020 | $1,544,000 | -35.9% | 148,969 | +0.1% | 0.02% | +4.2% |
| Q4 2019 | $2,408,000 | +20.2% | 148,769 | -1.4% | 0.02% | +9.1% |
| Q3 2019 | $2,004,000 | -5.6% | 150,869 | +0.1% | 0.02% | -4.3% |
| Q2 2019 | $2,123,000 | -24.6% | 150,669 | -1.5% | 0.02% | -25.8% |
| Q1 2019 | $2,815,000 | -44.7% | 152,958 | -21.5% | 0.03% | -53.0% |
| Q4 2018 | $5,090,000 | -26.7% | 194,769 | -35.6% | 0.07% | -1.5% |
| Q3 2018 | $6,945,000 | +20.5% | 302,630 | 0.0% | 0.07% | +17.5% |
| Q2 2018 | $5,765,000 | +13.1% | 302,630 | +0.0% | 0.06% | +9.6% |
| Q1 2018 | $5,099,000 | +3.0% | 302,610 | -7.1% | 0.05% | +10.6% |
| Q4 2017 | $4,949,000 | -17.6% | 325,585 | -2.9% | 0.05% | -4.1% |
| Q3 2017 | $6,004,000 | +6.3% | 335,426 | -3.2% | 0.05% | +2.1% |
| Q2 2017 | $5,646,000 | +15.3% | 346,359 | -0.9% | 0.05% | +14.3% |
| Q1 2017 | $4,895,000 | -12.6% | 349,621 | -0.5% | 0.04% | -8.7% |
| Q4 2016 | $5,602,000 | -28.5% | 351,241 | -25.4% | 0.05% | -24.6% |
| Q3 2016 | $7,837,000 | +48.7% | 470,965 | 0.0% | 0.06% | +35.6% |
| Q2 2016 | $5,270,000 | +40.8% | 470,965 | +5.2% | 0.04% | +25.0% |
| Q1 2016 | $3,743,000 | -10.0% | 447,733 | +0.2% | 0.04% | -10.0% |
| Q4 2015 | $4,158,000 | +106.0% | 446,646 | +149.7% | 0.04% | +90.5% |
| Q3 2015 | $2,018,000 | +43.9% | 178,881 | +61.9% | 0.02% | +23.5% |
| Q2 2015 | $1,402,000 | +36.5% | 110,486 | 0.0% | 0.02% | +41.7% |
| Q1 2015 | $1,027,000 | -35.1% | 110,486 | 0.0% | 0.01% | -33.3% |
| Q4 2014 | $1,583,000 | – | 110,486 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |